Chronic verapamil therapy in pediatrie and young adult patients with hypertrophic cardiomyopathy
- 1 June 1984
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 53 (11) , 1614-1619
- https://doi.org/10.1016/0002-9149(84)90589-7
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Hemodynamic effects of verapamil in children and adolescents with hypertrophic cardiomyopathy.Circulation, 1983
- Prediction of steady-state verapamil plasma concentrations in children and adultsClinical Pharmacology & Therapeutics, 1982
- Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy.Circulation, 1981
- Verapamil therapy: A new approach to the pharmacologic treatment of hypertrophic cardiomyopathy: III. Effects of long-term administrationThe American Journal of Cardiology, 1981
- Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy.Circulation, 1981
- Effect of verapamil on left ventricular isovolumic relaxation time and regional left ventricular filling in hypertrophic cardiomyopathyThe American Journal of Cardiology, 1980
- Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status.Circulation, 1979
- Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects.Circulation, 1979
- Treatment of hypertrophic obstructive cardiomyopathy with verapamil.Heart, 1979
- Methods of exercise testing: Step test, bicycle, treadmill, isometricsThe American Journal of Cardiology, 1974